{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:22:51Z","timestamp":1792513371948,"version":"4.5.0"},"reference-count":221,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP.02\/725\/46"],"award-info":[{"award-number":["RGP.02\/725\/46"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.seminoncol.2025.152410","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:57:21Z","timestamp":1758059841000},"page":"152410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ubiquitin-specific proteases in pancreatic cancer: Molecular regulators of tumor progression and therapy resistance"],"prefix":"10.1016","volume":"52","author":[{"given":"Jitendra","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqan N.","family":"Al-Khateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Zwenal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Alkhathami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malathi","family":"H","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Kundlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser Fakri","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Jawad","family":"Alnajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.hoc.2015.06.002","article-title":"Pancreatic cancer","volume":"29","author":"Wolpin","year":"2015","journal-title":"Hematol\/Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152410_bib0002","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","article-title":"Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention","volume":"164","author":"Stoffel","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0003","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","article-title":"Metabolism of pancreatic cancer: paving the way to better anticancer strategies","volume":"19","author":"Qin","year":"2020","journal-title":"Mol Cancer"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152410_bib0004","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2021.101783","article-title":"Hereditary pancreatic cancer","volume":"58-59","author":"Klatte","year":"2022","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0006","first-page":"1","article-title":"USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer","volume":"32","author":"Wang","year":"2024","journal-title":"Cell Death Different"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0007","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41418-020-00709-4","article-title":"Roles and mechanisms of BAP1 deubiquitinase in tumor suppression","volume":"28","author":"Masclef","year":"2021","journal-title":"Cell Death Different"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0008","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41467-022-29846-9","article-title":"USP22 regulates lipidome accumulation by stabilizing ppar\u03b3 in hepatocellular carcinoma","volume":"13","author":"Ning","year":"2022","journal-title":"Nat Commun"},{"issue":"36","key":"10.1016\/j.seminoncol.2025.152410_bib0009","article-title":"Deubiquitylating enzymes in cancer and immunity","volume":"10","author":"Ren","year":"2023","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13046-023-02792-0","article-title":"m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN\/PI3K\/AKT pathway","volume":"42","author":"Lin","year":"2023","journal-title":"J Experiment Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0011","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1038\/s41467-024-49450-3","article-title":"In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer","volume":"15","author":"Martinez","year":"2024","journal-title":"Nat Commun"},{"issue":"19-20","key":"10.1016\/j.seminoncol.2025.152410_bib0012","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.326314.119","article-title":"USP21 deubiquitinase promotes pancreas cancer cell stemness via wnt pathway activation","volume":"33","author":"Hou","year":"2019","journal-title":"Genes Develop"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0013","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.apsb.2024.01.006","article-title":"Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis","volume":"14","author":"Cheng","year":"2024","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0014","doi-asserted-by":"crossref","unstructured":"Hua Y-q, He Y, Ding X-b, et al. USP51, an oncogene for pancreatic cancer (PC) cell growth via wnt\/\u03b2-catenin pathway. 2020.","DOI":"10.21203\/rs.3.rs-20243\/v1"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0015","first-page":"251","article-title":"Cell cycle regulation in treatment of breast cancer","volume":"12","author":"Cai","year":"2017","journal-title":"Transl Res Breast Cancer"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056774","article-title":"Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt\/Skp2\/p27-associated pathway","volume":"8","author":"Luo","year":"2013","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.seminoncol.2025.152410_bib0017","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1038\/sj.onc.1208328","article-title":"Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer","volume":"24","author":"Radke","year":"2005","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0018","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ncb1847","article-title":"Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction","volume":"11","author":"Gao","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"7634","key":"10.1016\/j.seminoncol.2025.152410_bib0019","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nature20609","article-title":"Mechanism of early dissemination and metastasis in Her2+ mammary cancer","volume":"540","author":"Harper","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152410_bib0020","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/cas.15326","article-title":"Deubiquitinase ubiquitin-specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma","volume":"113","author":"Liu","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0021","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00432-011-0998-9","article-title":"Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer","volume":"137","author":"Zhang","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0022","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","article-title":"USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development","volume":"46","author":"Lin","year":"2012","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0023","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2017.08.040","article-title":"USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein","volume":"492","author":"Li","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0024","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/cbin.12024","article-title":"USP33 enhances cell survival and stemness by deubiquitinating CTNNB1 in BXPC-3 and SW1990 cells","volume":"47","author":"Zhong","year":"2023","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115359","article-title":"USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2","volume":"166","author":"Cui","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111033","article-title":"E3 ubiquitin ligase FBXW11 as a novel inflammatory biomarker is associated with immune infiltration and NF-\u03bab pathway activation in pancreatitis and pancreatic cancer","volume":"116","author":"Tan","year":"2024","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152410_bib0027","first-page":"623","article-title":"Therapy: Targeting E3 ubiquitin ligases for cancer therapy","volume":"2","author":"Sun","year":"2003","journal-title":"Cancer Bio Ther"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0028","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10555-017-9703-z","article-title":"E3 ubiquitin ligases in cancer and implications for therapies","volume":"36","author":"Wang","year":"2017","journal-title":"Cancer and Metastasis Rev"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152410_bib0029","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/ijc.28129","article-title":"A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer","volume":"133","author":"Satija","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152410_bib0030","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1002\/ctm2.1204","article-title":"The roles of E3 ubiquitin ligases in cancer progression and targeted therapy","volume":"13","author":"Sampson","year":"2023","journal-title":"Clin Transl Med"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152410_bib0031","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.228072","article-title":"HECT E3 ubiquitin ligases\u2013emerging insights into their biological roles and disease relevance","volume":"133","author":"Wang","year":"2020","journal-title":"J Cell Sci"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2016.02.006","article-title":"E3 ubiquitin ligases as novel targets for inflammatory diseases","volume":"106","author":"Goru","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0033","series-title":"Semin Cell Dev Biol","first-page":"167","article-title":"The E3 ubiquitin ligases regulate inflammation in cardiovascular diseases","volume":"2024","author":"Chen","year":"2024"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152410_bib0034","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.4161\/cc.8.11.8739","article-title":"DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors","volume":"8","author":"Hussain","year":"2009","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00280-020-04046-8","article-title":"The role of deubiquitinating enzymes in cancer drug resistance","volume":"85","author":"Tanguturi","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152410_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101077","article-title":"Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response","volume":"297","author":"Snyder","year":"2021","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152410_bib0037","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.drudis.2018.05.035","article-title":"Deubiquitinating enzymes in cancer stem cells: functions and targeted inhibition for cancer therapy","volume":"23","author":"Kaushal","year":"2018","journal-title":"Drug Discov Today"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152410_bib0038","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41571-018-0105-0","article-title":"Therapeutic strategies to target RAS-mutant cancers","volume":"15","author":"Ryan","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0039","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.12.273","article-title":"Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma","volume":"162","author":"Hosein","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neo.2022.01.002","article-title":"The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells","volume":"25","author":"Palanivel","year":"2022","journal-title":"Neoplasia"},{"issue":"24","key":"10.1016\/j.seminoncol.2025.152410_bib0041","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1158\/0008-5472.CAN-06-4471","article-title":"Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue","volume":"67","author":"Schmidt","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0042","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","article-title":"The Hippo pathway: biology and pathophysiology","volume":"88","author":"Ma","year":"2019","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0043","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/0008-5472.CAN-19-1704","article-title":"The tumor suppressor BAP1 regulates the Hippo pathway in pancreatic ductal adenocarcinoma","volume":"80","author":"Lee","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-021-03007-w","article-title":"E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1","volume":"19","author":"Deng","year":"2021","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152410_bib0045","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s10620-022-07780-6","article-title":"FBXO22 accelerates pancreatic cancer growth by deactivation of the hippo pathway via destabilizing LATS2","volume":"68","author":"Ma","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152410_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111837","article-title":"The sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model","volume":"41","author":"Tan","year":"2022","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152410_bib0047","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1021\/acs.jmedchem.0c01897","article-title":"Discovery of a Napabucasin PROTAC as an effective degrader of the E3 Ligase ZFP91","volume":"64","author":"Hanafi","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0048","first-page":"28","article-title":"The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer","volume":"140","author":"Su","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104634","article-title":"Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers","volume":"92","author":"El Kaoutari","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2024.106646","article-title":"ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation","volume":"175","author":"Cai","year":"2024","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0051","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41419-025-07550-y","article-title":"TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of Anti-PD-1 immunotherapy","volume":"16","author":"Mao","year":"2025","journal-title":"Cell Death Dis"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152410_bib0052","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1080\/15548627.2020.1847462","article-title":"Regulation and function of autophagy in pancreatic cancer","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0053","article-title":"PINK1 and PARK2 suppress pancreatic tumorigenesis through control of mitochondrial iron-mediated immunometabolism","volume":"46","author":"Li","year":"2018","journal-title":"EMBO J"},{"issue":"24","key":"10.1016\/j.seminoncol.2025.152410_bib0054","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.3390\/cancers13246204","article-title":"TGF\u03b2 drives metabolic perturbations during epithelial mesenchymal transition in pancreatic cancer: TGF\u03b2 induced EMT in PDAC","volume":"13","author":"Rajagopal","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0055","doi-asserted-by":"crossref","unstructured":"Choi SK, Pandiyan K, Eun JW, et al. Epigenetic landscape change analysis during human EMT sheds light on a key EMT mediator TRIM29. 2017, 8(58):98322.","DOI":"10.18632\/oncotarget.21681"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0056","doi-asserted-by":"crossref","unstructured":"Su D, Wang R, Chen G, et al. FBXO32 stimulates protein synthesis to drive pancreatic cancer progression and metastasis. 2024, 84(16):2607-2625.","DOI":"10.1158\/0008-5472.CAN-23-3638"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0057","doi-asserted-by":"crossref","unstructured":"Nelson JK, Thin MZ, Evan T, et al. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. 2022, 13(1):2070.","DOI":"10.1038\/s41467-022-29684-9"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0058","doi-asserted-by":"crossref","unstructured":"Voutsadakis IAJ: Mutations of p53 associated with pancreatic cancer and therapeutic implications. 2021, 25(3):315-327.","DOI":"10.14701\/ahbps.2021.25.3.315"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0059","doi-asserted-by":"crossref","unstructured":"Chen S, He Z, Zhu C, et al. TRIM37 mediates chemoresistance and maintenance of stemness in pancreatic cancer cells via ubiquitination of PTEN and activation of the AKT\u2013GSK-3\u03b2\u2013\u03b2-catenin signaling pathway. 2020, 10:554787.","DOI":"10.3389\/fonc.2020.554787"},{"issue":"20","key":"10.1016\/j.seminoncol.2025.152410_bib0060","first-page":"10897","article-title":"WNT enhancing signals in pancreatic cancer are transmitted by LGR6","volume":"15","author":"Wang","year":"2023","journal-title":"Aging"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152410_bib0061","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1080\/15548627.2020.1826689","article-title":"TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer","volume":"17","author":"Zhou","year":"2021","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0062","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-020-01237-y","article-title":"LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating wnt\/\u03b2-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.671022","article-title":"WNT Ligand dependencies in pancreatic cancer","volume":"9","author":"Aguilera","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"7592","key":"10.1016\/j.seminoncol.2025.152410_bib0064","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0065","first-page":"617","article-title":"Expression of neural precursor cell expressed developmentally downregulated 4-1 in pancreatic cancer tissue and its clinical significance","author":"BI","year":"2022","journal-title":"J Clin Hepatol"},{"issue":"17","key":"10.1016\/j.seminoncol.2025.152410_bib0066","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.3390\/cancers15174248","article-title":"Beta-transducin repeats-containing proteins as an anticancer target","volume":"15","author":"Kim","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10555-024-10226-2","article-title":"Reviews M: TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond","volume":"44","author":"Wu","year":"2025","journal-title":"Cancer and Metastasis Rev"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0068","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13577-020-00429-4","article-title":"Long noncoding RNA TSLNC8 enhances pancreatic cancer aggressiveness by regulating CTNNB1 expression via association with HuR","volume":"34","author":"Chai","year":"2021","journal-title":"Human Cell"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152410_bib0069","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1080\/15548627.2020.1826689","article-title":"TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer","volume":"17","author":"Zhou","year":"2021","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152410_bib0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41419-023-05871-4","article-title":"USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2\/tgf\u03b2 signaling pathway","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"issue":"20","key":"10.1016\/j.seminoncol.2025.152410_bib0071","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3390\/cancers13205086","article-title":"TGF\u03b2 signaling in the pancreatic tumor microenvironment","volume":"13","author":"Principe","year":"2021","journal-title":"Cancers"},{"issue":"5-6","key":"10.1016\/j.seminoncol.2025.152410_bib0072","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000108959","article-title":"Basics of TGF-\u03b2 and pancreatic cancer","volume":"7","author":"Truty","year":"2007","journal-title":"Pancreatology"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0073","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2017.10.007","article-title":"KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops","volume":"54","author":"Eibl","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.700315","article-title":"Biological significance of YAP\/TAZ in pancreatic ductal adenocarcinoma","volume":"11","author":"Hayashi","year":"2021","journal-title":"Front Oncol"},{"issue":"14","key":"10.1016\/j.seminoncol.2025.152410_bib0075","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112614","article-title":"YAP\/BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer","volume":"42","author":"Yamazaki","year":"2023","journal-title":"Embo J"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.113000","article-title":"Yap-myc signaling induces pancreatic stellate cell activation through regulating glutaminolysis","volume":"411","author":"Zhang","year":"2022","journal-title":"Experiment Cell Res"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152410_bib0077","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/ijc.31561","article-title":"A time for YAP1: tumorigenesis, immunosuppression and targeted therapy","volume":"143","author":"Shibata","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0078","doi-asserted-by":"crossref","unstructured":"Qin H, Sun R, Ning Z, et al. USP10 activates the FAK pathway by stabilizing RIOK3 in pancreatic ductal adenocarcinoma. 2024.","DOI":"10.21203\/rs.3.rs-3941004\/v1"},{"issue":"13","key":"10.1016\/j.seminoncol.2025.152410_bib0079","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.7150\/ijbs.92278","article-title":"USP10 promotes pancreatic ductal adenocarcinoma progression by attenuating FOXC1 protein degradation to activate the WNT signaling pathway","volume":"20","author":"Wang","year":"2024","journal-title":"Int J Biologic Sci"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molcel.2007.12.015","article-title":"The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression","volume":"29","author":"Zhang","year":"2008","journal-title":"Mol Cell"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152410_bib0081","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.4161\/cc.5.11.2796","article-title":"Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated pcg protein chromatin silencing pathway","volume":"5","author":"Glinsky","year":"2006","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0082","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1248\/bpb.b18-00646","article-title":"USP34 regulated human pancreatic cancer cell survival via AKT and PKC pathways","volume":"42","author":"Gu","year":"2019","journal-title":"Biologic Pharm Bulletin"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0083","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/1541-7786.MCR-12-0699","article-title":"Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival","volume":"11","author":"Burkhart","year":"2013","journal-title":"Mol Cancer Res"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0084","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41388-023-02847-8","article-title":"USP11 potentiates HGF\/AKT signaling and drives metastasis in hepatocellular carcinoma","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0085","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18017","article-title":"USP11 promotes glycolysis by regulating HIF-1\u03b1 stability in hepatocellular carcinoma","volume":"28","author":"Qiao","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0086","first-page":"1106","article-title":"Mir-320b inhibits pancreatic cancer cell proliferation by targeting FOXM1","volume":"22","author":"Jingyang","year":"2021","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0087","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1476-4598-12-159","article-title":"The roles of FOXM1 in pancreatic stem cells and carcinogenesis","volume":"12","author":"Quan","year":"2013","journal-title":"Mol Cancer"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152410_bib0088","first-page":"1970","article-title":"UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization","volume":"9","author":"Song","year":"2019","journal-title":"Am J Cancer Res"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0089","first-page":"4478","article-title":"The FOXM1\/ATX signaling contributes to pancreatic cancer development","volume":"12","author":"Xie","year":"2020","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.03.007","article-title":"FOXM1: a small fox that makes more tracks for cancer progression and metastasis","volume":"92","author":"Khan","year":"2023","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152410_bib0091","doi-asserted-by":"crossref","DOI":"10.1111\/boc.202400012","article-title":"FOXM1 transcriptional regulation","volume":"116","author":"Li","year":"2024","journal-title":"Biol Cell"},{"issue":"13","key":"10.1016\/j.seminoncol.2025.152410_bib0092","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-12-3859","article-title":"Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer","volume":"73","author":"Kong","year":"2013","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152410_bib0093","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/jcb.23150","article-title":"Over-expression of FoxM1 leads to epithelial\u2013mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells","volume":"112","author":"Bao","year":"2011","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0094","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbcan.2014.01.002","article-title":"FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis","volume":"1845","author":"Huang","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)-Rev Cancer"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0095","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11095-010-0106-x","article-title":"FoxM1 is a novel target of a natural agent in pancreatic cancer","volume":"27","author":"Wang","year":"2010","journal-title":"Pharmaceutic Res"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152410_bib0096","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/CS20180816","article-title":"STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer","volume":"133","author":"Liu","year":"2019","journal-title":"Clin Sci"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0097","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/1878-0261.12443","article-title":"Epigenetically modulated FOXM 1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer","volume":"13","author":"Zhou","year":"2019","journal-title":"Mol Oncol"},{"issue":"36","key":"10.1016\/j.seminoncol.2025.152410_bib0098","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1038\/onc.2016.14","article-title":"HGF\/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes","volume":"35","author":"Cui","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0099","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbagrm.2011.09.004","article-title":"FOXM1: From cancer initiation to progression and treatment","volume":"1819","author":"Koo","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regulat Mechan"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152410_bib0100","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1158\/1078-0432.CCR-13-2407","article-title":"FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression","volume":"20","author":"Cui","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152410_bib0101","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/onc.2015.208","article-title":"OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance","volume":"35","author":"Karunarathna","year":"2016","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0102","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/oncsis.2016.57","article-title":"RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment","volume":"5","author":"Kongsema","year":"2016","journal-title":"Oncogenesis"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152410_bib0103","doi-asserted-by":"crossref","first-page":"668","DOI":"10.15252\/embj.201592810","article-title":"Wnt-induced deubiquitination FoxM1 ensures nucleus \u03b2-catenin transactivation","volume":"35","author":"Chen","year":"2016","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152410_bib0104","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1517\/14728222.2011.566216","article-title":"Overcoming drug resistance in pancreatic cancer","volume":"15","author":"Long","year":"2011","journal-title":"Expert Opin Therap Targets"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-019-0435-2","article-title":"Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review","volume":"17","author":"Qin","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-10-37","article-title":"Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy","volume":"10","author":"Lister","year":"2011","journal-title":"Mol Cancer"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0107","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cell.2016.06.056","article-title":"NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer","volume":"166","author":"Chio","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216411","article-title":"Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma","volume":"576","author":"Li","year":"2023","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152410_bib0109","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.molcel.2019.12.024","article-title":"The G3BP1-family-USP10 deubiquitinase complex rescues ubiquitinated 40S subunits of ribosomes stalled in translation from lysosomal degradation","volume":"77","author":"Meyer","year":"2020","journal-title":"Mol Cell"},{"issue":"11","key":"10.1016\/j.seminoncol.2025.152410_bib0110","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1038\/emm.2017.128","article-title":"Modulating cellular balance of Rps3 mono-ubiquitination by both Hel2 E3 ligase and Ubp3 deubiquitinase regulates protein quality control","volume":"49","author":"Jung","year":"2017","journal-title":"Experim Mol Med"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152410_bib0111","first-page":"e751","article-title":"USP10 deubiquitylates and stabilizes DIRAS2 to suppress the growth of pancreatic cancer cells","volume":"5","author":"Chen","year":"2024","journal-title":"Med Comm (2020)"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0112","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41698-022-00336-x","article-title":"The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress","volume":"6","author":"Bhattacharya","year":"2022","journal-title":"NPJ Precision Oncol"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0113","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.7150\/thno.51712","article-title":"The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer","volume":"11","author":"Nie","year":"2021","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152410_bib0114","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3390\/cancers15072067","article-title":"NEK family review and correlations with patient survival outcomes in various cancer types","volume":"15","author":"Nguyen","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152410_bib0115","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/ijms26051992","article-title":"Targeting NEK kinases in gastrointestinal cancers: insights into gene expression, function, and inhibitors","volume":"26","author":"Chen","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.seminoncol.2025.152410_bib0116","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1074\/jbc.M110.104745","article-title":"Sensitivity to poly (ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair","volume":"285","author":"Wiltshire","year":"2010","journal-title":"J Biolog Chem"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0117","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/1541-7786.MCR-12-0699","article-title":"Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival","volume":"11","author":"Burkhart","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0118","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00268-005-0165-z","article-title":"Clinical significance of focal adhesion kinase in resectable pancreatic cancer","volume":"30","author":"Furuyama","year":"2006","journal-title":"World J Surg"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10116","article-title":"RIOK3 promotes pancreatic ductal adenocarcinoma cell invasion and metastasis by stabilizing FAK","volume":"8","author":"Xu","year":"2022","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152410_bib0120","first-page":"3750","article-title":"A systematic pan-cancer analysis identifies RIOK3 as an immunological and prognostic biomarker","volume":"14","author":"Li","year":"2022","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0121","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2022-327927","article-title":"FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer","volume":"73","author":"Canel","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0122","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00066-020-01666-0","article-title":"FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro","volume":"197","author":"Mohamed","year":"2021","journal-title":"Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0123","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal adhesion kinase: in command and control of cell motility","volume":"6","author":"Mitra","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"22","key":"10.1016\/j.seminoncol.2025.152410_bib0124","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/onc.2013.247","article-title":"KLF8 and FAK cooperatively enrich the active MMP14 on the cell surface required for the metastatic progression of breast cancer","volume":"33","author":"Lu","year":"2014","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152410_bib0125","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3760\/cma.j.issn.0366-6999.20130674","article-title":"Kr\u00fcpel-like factor 8 is a potential prognostic factor for pancreatic cancer","volume":"127","author":"Wei","year":"2014","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0126","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gene.2016.03.025","article-title":"KLF8 knockdown triggered growth inhibition and induced cell phase arrest in human pancreatic cancer cells","volume":"585","author":"Yi","year":"2016","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0127","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3390\/ijms23041998","article-title":"New insights on the nuclear functions and targeting of FAK in cancer","volume":"23","author":"Pomella","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152410_bib0128","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/j.gastro.2022.06.027","article-title":"Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-programmed cell death protein 1 therapy","volume":"163","author":"Blair","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-025-02262-5","article-title":"EIF4E-mediated biogenesis of circPHF14 promotes the growth and metastasis of pancreatic ductal adenocarcinoma via wnt\/\u03b2-catenin pathway","volume":"24","author":"Fang","year":"2025","journal-title":"Mol Cancer"},{"issue":"28","key":"10.1016\/j.seminoncol.2025.152410_bib0130","article-title":"Aberrant cholesterol metabolism and wnt\/\u03b2-catenin signaling coalesce via Frizzled5 in supporting cancer growth","volume":"9","author":"Zheng","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216040","article-title":"Pancreatic stellate cells exploit wnt\/\u03b2-catenin\/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth","volume":"555","author":"Liu","year":"2023","journal-title":"Cancer Lett"},{"issue":"17","key":"10.1016\/j.seminoncol.2025.152410_bib0132","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174242","article-title":"Wnt\/\u03b2-catenin signaling: the culprit in pancreatic carcinogenesis and therapeutic resistance","volume":"20","author":"Ram Makena","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119446","article-title":"USP7 imparts partial EMT state in colorectal cancer by stabilizing the RNA helicase DDX3X and augmenting wnt\/\u03b2-catenin signaling","volume":"1870","author":"Basu","year":"2023","journal-title":"Biochimica et Biophysica Acta Mol Cell Res"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152410_bib0134","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113511","article-title":"Oncogenic KRAS effector USP13 promotes metastasis in non-small cell lung cancer through deubiquitinating \u03b2-catenin","volume":"42","author":"Guo","year":"2023","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0135","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1007\/s10620-021-07226-5","article-title":"Overexpression of FOXC1 promotes tumor metastasis by activating the wnt\/\u03b2-catenin signaling pathway in gastric cancer","volume":"67","author":"Sun","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0136","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043219","article-title":"Ubiquitin-specific proteases (USPs) and metabolic disorders","volume":"24","author":"Kitamura","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152410_bib0137","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2326-6066.CIR-19-0661","article-title":"Tumor cell-intrinsic USP22 suppresses antitumor immunity in pancreatic cancer","volume":"8","author":"Li","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0138","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10549-006-9393-7","article-title":"Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics","volume":"104","author":"Deng","year":"2007","journal-title":"Breast Cancer Res Treatm"},{"issue":"17","key":"10.1016\/j.seminoncol.2025.152410_bib0139","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/MCB.24.17.7444-7455.2004","article-title":"BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage","volume":"24","author":"Schoenfeld","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-10-0893","article-title":"Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer","volume":"10","author":"Villarroel","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0141","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4161\/cbt.29182","article-title":"Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma","volume":"15","author":"Cox","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0142","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10911-010-9174-0","article-title":"Epithelial-to-mesenchymal transitions and circulating tumor cells","volume":"15","author":"Bonnomet","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"7277","key":"10.1016\/j.seminoncol.2025.152410_bib0143","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.seminoncol.2025.152410_bib0144","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4161\/cbt.21792","article-title":"Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil","volume":"13","author":"Harris","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0145","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00018-015-1851-0","article-title":"La FAM fatale: USP9X in development and disease","volume":"72","author":"Murtaza","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0146","first-page":"672","article-title":"Elevated expression of USP9X correlates with poor prognosis in human non-small cell lung cancer","volume":"7","author":"Wang","year":"2015","journal-title":"J Thorac Dis"},{"issue":"19-20","key":"10.1016\/j.seminoncol.2025.152410_bib0147","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.326314.119","article-title":"USP21 deubiquitinase promotes pancreas cancer cell stemness via wnt pathway activation","volume":"33","author":"Hou","year":"2019","journal-title":"Genes Dev"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152410_bib0148","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/cbin.11358","article-title":"USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the wnt\/\u03b2-catenin pathway via Axin1 deubiquitination","volume":"44","author":"Huang","year":"2020","journal-title":"Cell Biol Int"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0149","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1038\/s41467-019-12143-3","article-title":"USP7 inhibits wnt\/\u03b2-catenin signaling through promoting stabilization of axin","volume":"10","author":"Ji","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0150","doi-asserted-by":"crossref","unstructured":"Jiang S, Miao D, Wang M, Lv J, Wang Y, JJ Tong: MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP 22\/wnt\/\u03b2-catenin signaling axis. 2019, 23(1):630-640.","DOI":"10.1111\/jcmm.13968"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0151","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/0115748928297343240425055552","article-title":"USP31 Activates the wnt\/\u03b2-catenin signaling pathway and promotes gastric cancer cell proliferation, invasion and migration","volume":"20","author":"Li","year":"2025","journal-title":"Recent Patents Anti-cancer Drug Discov"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0152","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1038\/s41467-023-41836-z","article-title":"The USP46 complex deubiquitylates LRP6 to promote wnt\/\u03b2-catenin signaling","volume":"14","author":"Ng","year":"2023","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.seminoncol.2025.152410_bib0153","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1128\/MCB.00373-15","article-title":"Deubiquitinase USP47\/UBP64E regulates \u03b2-catenin ubiquitination and degradation and plays a positive role in wnt signaling","volume":"35","author":"Shi","year":"2015","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0154","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12935-019-0823-0","article-title":"Tre2 (USP6NL) promotes colorectal cancer cell proliferation via wnt\/\u03b2-catenin pathway","volume":"19","author":"Sun","year":"2019","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152410_bib0155","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47030155","article-title":"SJB2-043, a USP1 inhibitor, suppresses A549 cell proliferation, migration, and EMT via modulation of PI3K\/AKT\/mTOR, MAPK, and wnt signaling pathways","volume":"47","author":"Wu","year":"2025","journal-title":"Curr Issues Mol Biol"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152410_bib0156","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/0115665240258296231024112309","article-title":"USP3 inhibition is active against chemo-resistant hepatocellular carcinoma anchorage-independent growth via suppressing wnt\/\u03b2-catenin","volume":"24","author":"Xu","year":"2024","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0157","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fphar.2020.00668","article-title":"USP5 Promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition via wnt\/\u03b2-catenin pathway","volume":"11","author":"Xue","year":"2020","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152410_bib0158","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.molonc.2015.06.006","article-title":"Ubiquitin specific protease 4 positively regulates the WNT\/\u03b2-catenin signaling in colorectal cancer","volume":"9","author":"Yun","year":"2015","journal-title":"Mol Oncol"},{"issue":"26","key":"10.1016\/j.seminoncol.2025.152410_bib0159","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.3748\/wjg.v27.i26.4221","article-title":"Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the wnt\/\u03b2-catenin signaling pathway","volume":"27","author":"Zhong","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0160","doi-asserted-by":"crossref","unstructured":"Fu Y, Ma G, Liu G, et al. USP 14 as a novel prognostic marker promotes cisplatin resistance via Akt\/ERK signaling pathways in gastric cancer. 2018, 7(11):5577-5588.","DOI":"10.1002\/cam4.1770"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0161","doi-asserted-by":"crossref","unstructured":"Goldbraikh D, Neufeld D, Eid-Mutlak Y, et al. USP 1 deubiquitinates Akt to inhibit PI 3K-akt-FoxO signaling in muscle during prolonged starvation. 2020, 21(4):e48791.","DOI":"10.15252\/embr.201948791"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0162","doi-asserted-by":"crossref","unstructured":"Lan J, Zhang S, Zheng L, et al. PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT\/mTOR signaling pathway. 2023, 114(8):3190-3202.","DOI":"10.1111\/cas.15851"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0163","doi-asserted-by":"crossref","unstructured":"Li A, Wang S, Nie J, et al. USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K\/AKT signaling pathway. 2024, 15(3):235.","DOI":"10.1038\/s41419-024-06624-7"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152410_bib0164","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/onc.2012.66","article-title":"The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer","volume":"32","author":"Li","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0165","doi-asserted-by":"crossref","unstructured":"Ling S, Li J, Shan Q, et al. USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1\/AKT\/MRP1 signaling pathway. 2017, 11(6):682-695.","DOI":"10.1002\/1878-0261.12067"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0166","first-page":"417","article-title":"USP18 contributes to the proliferation and migration of ovarian cancer cells by regulating the AKT\/mTOR signaling pathway","volume":"69","author":"Liu","year":"2022","journal-title":"Acta Biochimica Polonica"},{"issue":"19","key":"10.1016\/j.seminoncol.2025.152410_bib0167","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/onc.2016.424","article-title":"TGF-\u03b2 upregulates the translation of USP15 via the PI3K\/AKT pathway to promote p53 stability","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0168","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2018.07.032","article-title":"USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma","volume":"436","author":"Lu","year":"2018","journal-title":"Cancer letters"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0169","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13046-019-1262-4","article-title":"USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer","volume":"38","author":"Man","year":"2019","journal-title":"J Experiment Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0170","doi-asserted-by":"crossref","unstructured":"Qu Z, Zhang R, Su M, WJ Liu: USP13 serves as a tumor suppressor via the PTEN\/AKT pathway in oral squamous cell carcinoma. 2019:9175-9183.","DOI":"10.2147\/CMAR.S186829"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0171","doi-asserted-by":"crossref","unstructured":"Sun J, Li T, Zhao Y, et al. USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN. 2018, 441:1-7.","DOI":"10.1007\/s11010-017-3170-2"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0172","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41420-023-01714-5","article-title":"USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K\/AKT signaling pathway","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0173","doi-asserted-by":"crossref","unstructured":"Wang Y, Luo X, Wu N, Liao Q, Wang JJ: USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4\/PI3K\/AKT axis. 2023, 19(1):97-107.","DOI":"10.4103\/jcrt.jcrt_517_22"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0174","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhang Y, Liu C, et al. Amplification of USP13 drives non-small cell lung cancer progression mediated by AKT\/MAPK signaling. 2019, 114:108831.","DOI":"10.1016\/j.biopha.2019.108831"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0175","doi-asserted-by":"crossref","unstructured":"Zhang H, Han Y, Xiao W, et al. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1. 2023, 14(11):730.","DOI":"10.1038\/s41419-023-06259-0"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152410_bib0176","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb2522","article-title":"USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-\u03b2 type I receptor","volume":"14","author":"Zhang","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0177","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12885-024-12009-y","article-title":"USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2\/AKT\/P62 axis","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152410_bib0178","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/kjm2.12096","article-title":"Ubiquitin-specific protease 44 inhibits cell growth by suppressing AKT signaling in non-small cell lung cancer","volume":"35","author":"Zhang","year":"2019","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0179","doi-asserted-by":"crossref","unstructured":"Zhiqiang Z, Qinghui Y, Yongqiang Z, et al. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells. 2012, 138:1231-1238.","DOI":"10.1007\/s00432-012-1193-3"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152410_bib0180","first-page":"1115","article-title":"USP4 promotes invasion of breast cancer cells via Relaxin\/TGF-\u03b21\/Smad2\/MMP-9 signal","volume":"20","author":"Cao","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0181","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1038\/ncomms6399","article-title":"The DUSP-Ubl domain of USP4 enhances its catalytic efficiency by promoting ubiquitin exchange","volume":"5","author":"Clerici","year":"2014","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152410_bib0182","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.2619","article-title":"USP15 stabilizes TGF-\u03b2 receptor I and promotes oncogenesis through the activation of TGF-\u03b2 signaling in glioblastoma","volume":"18","author":"Eichhorn","year":"2012","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152410_bib0183","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/15384101.2021.1874695","article-title":"USP1-WDR48 deubiquitinase complex enhances TGF-\u03b2 induced epithelial-mesenchymal transition of TNBC cells via stabilizing TAK1","volume":"20","author":"Han","year":"2021","journal-title":"Cell Cycle (Georgetown, Tex)"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152410_bib0184","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41419-021-04176-8","article-title":"USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/jgh.15244","article-title":"Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transforming growth factor-\u03b2 receptors in patients with pancreatic ductal adenocarcinoma","volume":"36","author":"Jiang","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0186","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/0008-5472.CAN-18-0753","article-title":"TGF\u03b2-activated USP27X deubiquitinase regulates cell migration and chemoresistance via stabilization of Snail1","volume":"79","author":"Lambies","year":"2019","journal-title":"Cancer Res"},{"issue":"19","key":"10.1016\/j.seminoncol.2025.152410_bib0187","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/onc.2016.424","article-title":"TGF-\u03b2 upregulates the translation of USP15 via the PI3K\/AKT pathway to promote p53 stability","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152410_bib0188","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.18632\/aging.101587","article-title":"Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-\u03b2 signaling-induced epithelial-mesenchymal transition","volume":"10","author":"Qiu","year":"2018","journal-title":"Aging"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0189","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.103734","article-title":"Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in epithelial to mesenchymal transition (EMT) induced by TGF\u03b22 in breast cells","volume":"219","author":"Silvestrini","year":"2020","journal-title":"J Proteom"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152410_bib0190","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.7150\/jca.92386","article-title":"USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination","volume":"15","author":"Wang","year":"2024","journal-title":"J Cancer"},{"issue":"16","key":"10.1016\/j.seminoncol.2025.152410_bib0191","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108791","article-title":"USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-\u03b2 receptor t\u03b2rii","volume":"41","author":"Xie","year":"2022","journal-title":"EMBO J"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0192","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116319","article-title":"Ubiquitin-specific peptidase 15 regulates the TFAP4\/PCGF1 axis facilitating liver metastasis of colorectal cancer and cell stemness","volume":"226","author":"Yin","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0193","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/1878-0261.12596","article-title":"Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein","volume":"14","author":"Yuan","year":"2020","journal-title":"Mol Oncol"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0194","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00018-022-04672-w","article-title":"Opposing USP19 splice variants in TGF-\u03b2 signaling and TGF-\u03b2-induced epithelial\u2013mesenchymal transition of breast cancer cells","volume":"80","author":"Zhang","year":"2023","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152410_bib0195","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.celrep.2018.02.007","article-title":"USP2a Supports metastasis by tuning TGF-\u03b2 signaling","volume":"22","author":"Zhao","year":"2018","journal-title":"Cell Rep"},{"issue":"18","key":"10.1016\/j.seminoncol.2025.152410_bib0196","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1158\/0008-5472.CAN-14-1211","article-title":"Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer","volume":"74","author":"Pal","year":"2014","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.seminoncol.2025.152410_bib0197","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.3390\/ijms22094546","article-title":"Advances in the development ubiquitin-specific peptidase (USP) inhibitors","volume":"22","author":"Chen","year":"2021","journal-title":"Int J Mol Scis"},{"issue":"32","key":"10.1016\/j.seminoncol.2025.152410_bib0198","doi-asserted-by":"crossref","DOI":"10.12998\/wjcc.v10.i32.11690","article-title":"Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment","volume":"10","author":"Huang","year":"2022","journal-title":"World J Clin Cases"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152410_bib0199","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquity-lating enzyme specificity begets function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13046-023-02805-y","article-title":"Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application","volume":"42","author":"Gao","year":"2023","journal-title":"J Experiment Clin Cancer Res"},{"issue":"7677","key":"10.1016\/j.seminoncol.2025.152410_bib0201","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature24006","article-title":"USP7 small-molecule inhibitors interfere with ubiquitin binding","volume":"550","author":"Kategaya","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152410_bib0202","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2326-6066.CIR-19-0661","article-title":"Tumor cell\u2013intrinsic USP22 suppresses antitumor immunity in pancreatic cancer","volume":"8","author":"Li","year":"2020","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152410_bib0203","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/2326-6066.CIR-18-0910","article-title":"USP22 Deubiquitinates CD274 to suppress anticancer immunity","volume":"7","author":"Huang","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0204","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1186\/s12885-022-10424-7","article-title":"ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration","volume":"22","author":"Cui","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0205","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","article-title":"USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer","volume":"13","author":"Shi","year":"2022","journal-title":"Nat Commun"},{"issue":"38","key":"10.1016\/j.seminoncol.2025.152410_bib0206","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101592118","article-title":"Therapeutic inhibition of USP9x-mediated notch signaling in triple-negative breast cancer","volume":"118","author":"Jaiswal","year":"2021","journal-title":"Proceed Natl Acad Sci"},{"issue":"7677","key":"10.1016\/j.seminoncol.2025.152410_bib0207","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature24451","article-title":"Molecular basis of USP7 inhibition by selective small-molecule inhibitors","volume":"550","author":"Turnbull","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0208","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3389\/fphar.2018.01080","article-title":"Inhibition of ubiquitin-specific proteases as a novel anticancer therapeutic strategy","volume":"9","author":"Yuan","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0209","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116071","article-title":"Identification of YCH2823 as a novel USP7 inhibitor for cancer therapy","volume":"222","author":"Cheng","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152410_bib0210","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.molcel.2018.10.045","article-title":"USP1 Is required for replication fork protection in BRCA1-deficient tumors","volume":"72","author":"Lim","year":"2018","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152410_bib0211","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/biom15020240","article-title":"Ubiquitin-specific protease inhibitors for cancer therapy: recent advances and future prospects","volume":"15","author":"Bakkar","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0212","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0959-8049(20)31215-6","article-title":"Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers","volume":"138","author":"Cadzow","year":"2020","journal-title":"Eur J Cancer"},{"issue":"17","key":"10.1016\/j.seminoncol.2025.152410_bib0213","doi-asserted-by":"crossref","first-page":"15557","DOI":"10.1021\/acs.jmedchem.4c01184","article-title":"Structural and biochemical insights into the mechanism of action of the clinical USP1 inhibitor, KSQ-4279","volume":"67","author":"Rennie","year":"2024","journal-title":"J Med Chem"},{"issue":"8_Supplement_1","key":"10.1016\/j.seminoncol.2025.152410_bib0214","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1158\/1538-7445.AM2025-5723","article-title":"XL309 is a potent, selective, and orally bioavailable USP1 inhibitor active as monotherapy and in combination with PARP inhibitors or irinotecan","volume":"85","author":"Charruyer-Reinwald","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116568","article-title":"Design, synthesis, and biological evaluation of pyrido [2, 3-d] pyrimidin-7 (8H)-one derivatives as potent USP1 inhibitors","volume":"275","author":"Li","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"20","key":"10.1016\/j.seminoncol.2025.152410_bib0216","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1158\/0008-5472.CAN-24-0293","article-title":"The USP1 inhibitor KSQ-4279 overcomes PARP inhibitor resistance in homologous recombination\u2013Deficient tumors","volume":"84","author":"Cadzow","year":"2024","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152410_bib0217","article-title":"The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells","volume":"6","author":"Wang","year":"2016","journal-title":"Scient Rep"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0218","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s10637-020-00915-4","article-title":"Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and\/or refractory multiple myeloma","volume":"38","author":"Rowinsky","year":"2020","journal-title":"Investig New Drugs"},{"key":"10.1016\/j.seminoncol.2025.152410_bib0219","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144960","article-title":"The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma","volume":"758","author":"Bai","year":"2020","journal-title":"Gene"},{"issue":"21","key":"10.1016\/j.seminoncol.2025.152410_bib0220","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1038\/onc.2016.445","article-title":"EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis","volume":"36","author":"Wang","year":"2017","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152410_bib0221","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb2522","article-title":"USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-\u03b2 type I receptor","volume":"14","author":"Zhang","year":"2012","journal-title":"Nat Cell Biol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:39:09Z","timestamp":1778665149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":221,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0093775425001022"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152410","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitin-specific proteases in pancreatic cancer: Molecular regulators of tumor progression and therapy resistance","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152410"}}